Vascular Anomalies

  • Philip John


The International Society for the Study of Vascular Anomalies classifies vascular anomalies into vascular tumors and vascular malformations. This division is based on the biological and clinical behavior of these anomalies (including physical characteristics, natural history, and cellular features). Its usage provides a common language for most diagnoses.

Infantile hemangioma is the commonest vascular tumor, initially presenting a few weeks after birth. Fetal hypoxic stress is considered a likely trigger for the development of these tumors; however, placental emboli have previously been implicated as they share pathological features in common. Although most vascular tumors are not associated with vascular malformations, the so-called “segmental” type of infantile hemangioma may be associated with developmental vascular and other anomalies, as in PHACES syndrome.


Vascular Malformation Venous Malformation Infantile Hemangioma Lymphatic Malformation Sodium Tetradecyl Sulfate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Enjolras O, Wassef M, Chapot R. ISSVA classifications, color atlas of vascular tumors and vascular malformations. New York: Cambridge University Press; 2007.CrossRefGoogle Scholar
  2. 2.
    Hartemink DA, Chiu YE, Drolet BA, Kerschner JE. PHACES syndrome: a review. Int J Pediatr Otorhinolaryngol. 2009;73(2):181–7.PubMedCrossRefGoogle Scholar
  3. 3.
    Frieden I, Enjolras O, Esterly N. Vascular birthmarks and other abnormalities of blood vessels and lymphatics. In: Schachner LA, Hansen RC, editors. Pediatric dermatology. 3rd ed, Chapter 20. St. Louis: Mosby; 2003. p. 833–62.Google Scholar
  4. 4.
    Burrows PE, Laor T, Paltiel H, Robertson RL. Diagnostic imaging in the evaluation of vascular birthmarks. Pediatr Dermatol. 1998;16(3):455–88.Google Scholar
  5. 5.
    Luu M, Frieden IJ. Hemangioma: clinical course, complications and management. Br J Dermatol. 2013;169(1):20–30.PubMedCrossRefGoogle Scholar
  6. 6.
    Mulliken JB, Enjolras O. Congenital hemangiomas and infantile hemangiomas: missing links. J Am Acad Dermatol. 2004;50:875–82.PubMedCrossRefGoogle Scholar
  7. 7.
    Gorincour G, Kokta V, Rypens F, et al. Imaging characteristics of two subtypes of congenital hemangiomas: rapidly involuting congenital hemangiomas and non-involuting congenital hemangiomas. Pediatr Radiol. 2005;35:1178–85.PubMedCrossRefGoogle Scholar
  8. 8.
    Christison-Legay ER, Burrows PE, Alomari A, et al. Hepatic hemangiomas: subtype classification and development of a clinical practice algorithm and registry. J Pediatr Surg. 2007;42:62–8.CrossRefGoogle Scholar
  9. 9.
    Kassarjian A, Zurakowski D, Dubois J, et al. Infantile hepatic hemangiomas: clinical and imaging findings and their correlation with therapy. AJR Am J Roentgenol. 2004;182:785–95.PubMedCrossRefGoogle Scholar
  10. 10.
    McHugh K, Burrows PE. Infantile hepatic hemangioendotheliomas: significance of portal venous and systemic collateral arterial supply. J Vasc Interv Radiol. 1992;3(2):337–44.PubMedCrossRefGoogle Scholar
  11. 11.
    Drolet BA, Trenor III CC, Brandão LR, et al. Consensus-derived practice standards plan for complicated kaposiform hemangioendothelioma. J Pediatr. 2013;163(1):285–91.PubMedCrossRefGoogle Scholar
  12. 12.
    Enjolras O, Mulliken JB, Wassef M, et al. Residual lesions after Kasabach-Merritt phenomenon in 41 patients. J Am Acad Dermatol. 2000;42:225–35.PubMedCrossRefGoogle Scholar
  13. 13.
    Ryan C, Price V, John P, et al. Kasabach-Merritt phenomenon: a single centre experience. Eur J Haematol. 2010;84(2):97–104.PubMedCrossRefGoogle Scholar
  14. 14.
    Tan OT, Sherwood K, Gilchrest BA. Treatment of children with port-wine stains using the flashlamp pumped tunable dye laser. N Engl J Med. 1989;320:416–21.PubMedCrossRefGoogle Scholar
  15. 15.
    Hassanein AH, Mulliken JB, Fishman SJ, et al. Lymphatic malformation: risk of progression during childhood and adolescence. J Craniofac Surg. 2012;23(1):149–52.PubMedCrossRefGoogle Scholar
  16. 16.
    Cahill AM, Nijs E, Ballah D, et al. Percutaneous sclerotherapy in neonatal and infant head and neck lymphatic malformations: a single center experience. J Pediatr Surg. 2011;46(11):2083–95.PubMedCrossRefGoogle Scholar
  17. 17.
    Shergill A, John P, Amaral JG. Doxycycline sclerotherapy in children with lymphatic malformations: outcomes, complications and clinical efficacy. Pediatr Radiol. 2012;42(9):1080–8.PubMedCrossRefGoogle Scholar
  18. 18.
    Swetman GL, Berk DR, Vasanawala SS, et al. Sildenafil for severe lymphatic malformations. N Engl J Med. 2012;366(4):384–6.PubMedCrossRefGoogle Scholar
  19. 19.
    Hammill AM, Wentzel M, Gupta A, et al. Sirolimus for the treatment of complicated vascular anomalies in children. Pediatr Blood Cancer. 2011;57(6):1018–24.PubMedCrossRefGoogle Scholar
  20. 20.
    Greene AK, Perlyn CA, Alomari AI. Management of lymphatic malformations. Clin Plast Surg. 2011;38:75–82.PubMedCrossRefGoogle Scholar
  21. 21.
    Cuervo JL, Galli E, Eisele G, et al. Lymphatic malformations: percutaneous treatment with bleomycin. Arch Argent Pediatr. 2011;109(5):417–22.PubMedCrossRefGoogle Scholar
  22. 22.
    Bai Y, Jia J, Huang XX, et al. Sclerotherapy of microcystic lymphatic malformations in oral and facial regions. J Oral Maxillofac Surg. 2009;67(2):251–6.PubMedCrossRefGoogle Scholar
  23. 23.
    Yang Y, Sun M, Ma Q, Cheng X, Ao J, Tian L, et al. Bleomycin A5 sclerotherapy for cervicofacial lymphatic malformations. J Vasc Surg. 2011;53(1):150–5.PubMedCrossRefGoogle Scholar
  24. 24.
    Dompmartin A, Vikkula M, Boon LM. Venous malformation: update on aetiopathogenesis, diagnosis and management. Phlebology. 2010;25(5):224–35.PubMedCentralPubMedCrossRefGoogle Scholar
  25. 25.
    Hassanein AH, Mulliken JB, Fishman SJ, et al. Venous malformation: risk of progression during childhood and adolescence. Ann Plast Surg. 2012;68(2):198–201.PubMedCrossRefGoogle Scholar
  26. 26.
    Mazoyer E, Enjolras O, Laurian C, et al. Coagulation abnormalities associated with extensive venous malformations of the limbs: differentiation from Kasabach-Merritt syndrome. Clin Lab Haematol. 2002;24:243–51.PubMedCrossRefGoogle Scholar
  27. 27.
    Mazoyer E, Enjolras O, Bisdorff A, et al. Coagulation disorders in patients with venous malformation of the limbs and trunk: a case series of 118 patients. Arch Dermatol. 2008;144(7):861–7.PubMedCrossRefGoogle Scholar
  28. 28.
    Dompmartin A, Acher A, Thibon P, et al. Association of localized intravascular coagulopathy with venous malformations. Arch Dermatol. 2008;144(7):873–7.PubMedCrossRefGoogle Scholar
  29. 29.
    Rodriguez-Manero M, Aguado L, Redondo P. Pulmonary arterial hypertension in patients with slow-flow vascular malformations. Arch Dermatol. 2010;146(12):1347–52.PubMedCrossRefGoogle Scholar
  30. 30.
    Burrows PE. Endovascular treatment of slow-flow vascular malformations. Tech Vasc Interv Radiol. 2013;16(1):12–21.PubMedCrossRefGoogle Scholar
  31. 31.
    Goyal M, Causer PA, Armstrong D. Venous vascular malformations in pediatric patients: comparison of results of alcohol sclerotherapy with proposed MR imaging classification. Radiology. 2002;223(3):639–44.PubMedCrossRefGoogle Scholar
  32. 32.
    Tieu DD, Ghodke BV, Vo NJ, Perkins JA. Single-stage excision of localized head and neck venous malformations using preoperative glue embolization. Otolaryngol Head Neck Surg. 2013;148(4):678–84.PubMedCrossRefGoogle Scholar
  33. 33.
    Berenguer B, Burrows PE, Zurakowski D, Mulliken JB. Sclerotherapy of craniofacial venous malformations: complications and results. Plast Reconstr Surg. 1999;104(1):1–11.PubMedCrossRefGoogle Scholar
  34. 34.
    Barranco-Pons R, Burrows PE, Landrigan-Ossar M, et al. Gross hemoglobinuria and oliguria are common transient complications of sclerotherapy for venous malformations: review of 475 procedures. AJR Am J Roentgenol. 2012;199(3):691–4.PubMedCrossRefGoogle Scholar
  35. 35.
    Arnold R, Chaudry G. Diagnostic imaging of vascular anomalies. Clin Plast Surg. 2011;38(1):21–9.PubMedCrossRefGoogle Scholar
  36. 36.
    Greene AK, Orbach DB. Management of arteriovenous malformations. Clin Plast Surg. 2011;38(1):95–106.PubMedCrossRefGoogle Scholar
  37. 37.
    Lee BB, Baumgartner I, Berlien HP, et al. Consensus Document of the International Union of Angiology (IUA)-2013. Current concept on the management of arterio-venous management. Int Angiol. 2013;32(1):9–36.PubMedGoogle Scholar
  38. 38.
    Yakes WF. Endovascular management of high-flow arteriovenous malformations. Semin Intervent Radiol. 2004;21(1):49–58.PubMedCentralPubMedCrossRefGoogle Scholar
  39. 39.
    Do YS, Yakes WF, Shin SW. Ethanol embolization of arteriovenous malformations: interim results. Radiology. 2005;235(2):674–82.PubMedCrossRefGoogle Scholar
  40. 40.
    Jackson JE, Mansfield AO, Allison DJ. Treatment of high-flow vascular malformations by venous embolization aided by flow occlusion techniques. Cardiovasc Intervent Radiol. 1996;19(5):323–8.PubMedCrossRefGoogle Scholar
  41. 41.
    Houbballah R, Mallios A, Poussier B, et al. A new therapeutic approach to congenital pelvic arteriovenous malformations. Ann Vasc Surg. 2010;24(8):1102–9.PubMedCrossRefGoogle Scholar
  42. 42.
    Pollak JS, White Jr RI. The use of cyanoacrylate adhesives in peripheral embolization. J Vasc Interv Radiol. 2001;12(8):907–13.PubMedCrossRefGoogle Scholar
  43. 43.
    Al-Saleh S, John PR, Letarte M, et al. Symptomatic liver involvement in neonatal hereditary hemorrhagic telangiectasia. Pediatrics. 2011;127(6):e1615–20.PubMedCentralPubMedCrossRefGoogle Scholar
  44. 44.
    Jacob AG, Driscoll DJ, Shaughnessy WJ, et al. Klippel-Trenaunay syndrome: spectrum and management. Mayo Clin Proc. 1998;73:28–36.PubMedCrossRefGoogle Scholar
  45. 45.
    Gloviczki P, Driscoll DJ. Klippel-Trenaunay syndrome: current management. Phlebology. 2007;22(6):291–8.PubMedCrossRefGoogle Scholar
  46. 46.
    Lee A, Driscoll D, Gloviczki P, et al. Evaluation and management of pain in patients with Klippel-Trenaunay syndrome: a review. Pediatrics. 2005;115:744–9.PubMedCrossRefGoogle Scholar
  47. 47.
    Ahmad I, Alomari MD. Diversion venography—a modified technique in Klippel-Trenaunay syndrome: initial experience. J Vasc Interv Radiol. 2010;21(5):685–9.CrossRefGoogle Scholar
  48. 48.
    Revencu N, Boon LM, Mulliken JB, et al. Parkes Weber syndrome, vein of Galen aneurysmal malformation, and other fast-flow vascular anomalies are caused by RASA1 mutations. Hum Mutat. 2008;29(7):959–65.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  1. 1.Department of Diagnostic ImagingThe Hospital for Sick ChildrenTorontoCanada

Personalised recommendations